drugset
Drugs / LAIV4
last change Mar 2020 re-read 3 minutes ago

LAIV4

Vaccine

Developed for
influenza
Investigated by
Centers for Disease Control and Prevention · Children's Hospital Medical Center, Cincinnati · Duke University · Vanderbilt University Medical Center

Trials 1

today NCT03600428 · Ph 4
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03600428 Oct 2018 → Mar 2020 childhood onset asthma, influenza, vaccinia Vanderbilt University Medical Center Completed Met primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LAIV4 “quadrivalent live attenuated influenza vaccine (LAIV4)” NCT03600428 ↗
Modality Vaccine “quadrivalent live attenuated influenza vaccine (LAIV4)” NCT03600428 ↗
Route Intranasal “1 dose, 0.2 mL, intranasal administration” NCT03600428 ↗